Tango Therapeutics TNGX Shares (Diluted)
Discontinued — last reported Q1 '26
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Tango Therapeutics's shares (diluted)?
- Tango Therapeutics (TNGX) reported shares (diluted) of 143.6M in Q1 2026.
- How has Tango Therapeutics's shares (diluted) changed year-over-year?
- Tango Therapeutics's shares (diluted) increased by 30.2% year-over-year, from 110.3M to 143.6M.
- What is the long-term trend for Tango Therapeutics's shares (diluted)?
- Over 4 years (2021 to 2025), Tango Therapeutics's shares (diluted) has grown at a 19.6% compound annual growth rate (CAGR), from 222.4M to 454.8M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.